NASDAQ:IOVA

Iovance Biotherapeutics Stock News

etoro logo Buy IOVA
*Your capital is at risk
$3.79
-0.310 (-7.56%)
At Close: Jun 03, 2026
SAN CARLOS, Calif., Aug. 07, 2020 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, today annou
Enrollment Completed in Pivotal Cohort 1 of C-145-04 Cervical Cancer StudySAN CARLOS, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) ABIOMED, Inc. (NASDAQ: ABMD) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) (announced a U.S. government grant for a...
Legend Biotech Corporation (NASDAQ:LEGN) announced today that the China Center for Drug Evaluation, National Medical Products Administration (CDE, NMP
One important metric to look for in a stock is an 80 or higher Relative Strength Rating. When you're researching the best stocks to buy and watch, be sure to pay attention to relative price strength.
Dupont Capital Management Corp cut its stake in shares of Iovance Biotherapeutics Inc (NASDAQ:IOVA) by 2.5% during the second quarter, according to the company in its most recent filing with the Secur
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts. COVID-19 news flow continued to pour in,...
SAN CARLOS, Calif., July 23, 2020 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, will report
Advisor Group Holdings Inc. purchased a new position in Iovance Biotherapeutics Inc (NASDAQ:IOVA) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission.
U.S. Supreme Court's Ginsburg undergoing treatment for cancer recurrence
Guru ups bet in biotech focused on ear-related disorders Continue reading...
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
Evanson Asset Management LLC lessened its holdings in shares of Iovance Biotherapeutics Inc (NASDAQ:IOVA) by 35.6% in the 2nd quarter, according to the company in its most recent 13F filing with the S
FHI Clinical Inc. contracted by Frederick National Laboratory for Cancer Research to provide operational support for NIAID-funded study
About 1,400 women die from breast cancer every day around the world.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE